ESICM LIVES virtual congress 2021

Xenios took part at ESICM LIVES from 03-06 October 2021! To ensure that everyone can participate, LIVES 2021 was again a fully digital event. The congress offered discussions and debates, abstract presentations, scientific sessions, live votings and demonstrations. We again presented our virtual ICU to show our product and treatment portfolio ...

First installation & training session in China

Happy to share some good news! The first installation and training session with the Xenios console in China mainland was successfully completed. Thanks to the Fresenius Medical Care China & Fresenius Medical Care Asia-Pacific Team for their effort and passion!

ISICEM virtual congress 2021

Xenios took part in ISICEM virtual congress, August 31 - September 03, 2021. We showed our treatment and product portfolio in our virtual ICU via a VV ECMO patient case. Get an idea about our virtual ICU: http://ow.ly/kbkr50FWbTl

Xenios AG receives approval in China for ECMO devices

Xenios AG, a Fresenius Medical Care company, has received approval from the National Medical Products Administration (NMPA) in China for the Xenios console and patient kits for ECMO therapy. In early May, Xenios AG, a Fresenius Medical Care company, received approval for two patient kits in China. It follows NMPA’s ...

EuroELSO 2021 Virtual Congress

Meet Fresenius Medical Care Heart & Lung (Xenios) at EuroELSO 2021 and join our symposium! In our virtual ICU, you will learn about our products and therapies directly on a VV ECMO patient case. Talk to our experts via text chat and ask all your questions. Also, join us for our ...

The Management Board of Xenios AG, the Heart & Lung Business Unit of Fresenius Medical Care, has been restructured. Effective January 31, 2021, the previous Chair of the Executive Board, Dr. Andreas Terpin, has left the company. The new senior trio on the Management Board will continue Fresenius Medical ...